Ginkgo Biloba extracto de polvo a granel

¿Qué es el polvo de extracto de Ginkgo Biloba?

El polvo de extracto de Ginkgo biloba es un polvo fluíble amarillo-marrón claro extraído de las hojas secas de Ginkgo biloba L., una planta de la familia Ginkgoaceae, usando solventes apropiados, el ingrediente activo. Sus principales componentes son ginkgo total flavonoides, ginkgolides, y otras sustancias, con son vasodilat, que protegen el tejido endotelial de los vasos sanguíneos, la regulación de los lípidos de la sangre, la protección de las lipoproteínas de baja densidad, la inhibición de PAF (factor activador de plaquetas), la inhibición de la trombo, la eliminación de los radicales libres, etc. El 27 de octubre de 2017, la organización mundial de la salud, la agencia internacional para la investigación del cáncer, publicó el cotejo preliminar de la lista de referencias cancerígenas, el extracto de hoja de ginkgo biloba está en la lista de carcinógenos del grupo 2B.

Polvo de extracto de Ginkgo biloba Otros productos a granel Suministrada por Green La tecnología de primavera se aplica estrictamente por las normas de la UE, y todo el proceso de producción es controlado y trazable desde las materias primas hasta los productos terminados. Las pruebas de diversos contaminantes se llevan a cabo de acuerdo con los más altos estándares de la UE, y podemos proporcionar informes de pruebas autorizados de terceros. Este polvo de extracto de Ginkgo biloba tiene un alto contenido, buena solubilidad en agua y calidad estable, y ha sido ampliamente utilizado en productos para el cuidado de la salud, alimentos, medicina y otros campos.

Especificaciones:

Reglamento:

Se ajusta a la normativa de la UE.

Benefits:

Scavenging Free Radicals

Ginkgo biloba leaf extract can directly scavenge lipid radicals, lipid peroxidation radicals alkyl radicals, etc., and terminate the chain reaction chain of free radicals. It is also involved in regulating and enhancing the activity of antioxidant enzymes such as peroxide dismutase, glutathione peroxidase, etc. The antioxidant effect of flavonoids in ginkgo biloba extract even exceeds that of vitamins, and it has anti-free radical attack properties in vitro.

It has been demonstrated that the addition of different concentrations of ginkgo biloba leaf extract to different reaction systems can convert free radical products such as OH to non-free radical products. Ginkgo biloba extract scavenges in a manner similar to the antiradical effect of uric acid, and it also inhibits the free radicals produced by warming doxorubicin with liver microsomes P-450 and reduces the production of the lipid peroxide malondialdehyde (MDA). Since Ginkgo biloba extract is characterized by 2 components, hydrophilic and lipophilic, its therapeutic effect is superior to that of any single component.

Cardioprotection

Ginkgo biloba leaf extract has vasodilatory and cardioprotective effects and has significant therapeutic effects on cardiac ischaemia, allergic disorders, and infectious shock. In rabbit heart ischemia-reperfusion experiments, intracoronary injection of Ginkgo biloba extract can significantly inhibit the increase of MDA in plasma and myocardial tissue. The degree of damage to myocardial cells observed by electron microscopy was also significantly less than that of the control group. It also protected plasma tissue-type plasminogen activator (tPA) at a higher level and reduced PAI-1, an effect that may be beneficial by regulating fibrinolytic activity.

Protection Against Cerebral Ischaemia

The protective effect of Ginkgo biloba extract on cerebral ischaemia and cerebral oedema was observed in both the carotid artery ligation model and the rat cerebral oedema model of cerebral ischaemia and cerebral oedema. By maintaining the normal respiration of intracellular mitochondria, Ginkgo biloba prevented the disturbance of ion transport in the cell membrane caused by cerebral ischemia and prevented intracellular Ca2+ overload and brain cell damage. In cerebral infarction test, Ginkgo biloba extract can reduce the scope of focal cerebral infarction and improve the neurobehavioural disorders caused by ischemia. At the same time, Ginkgo biloba leaf extracts and Bilobalide had the effects of anti-ischemia-induced neuronal cell death and reduced mitochondrial gene expression.

Protection of Neurons

Flavonoids have a free radical scavenging effect and attenuate mitochondria-mediated apoptosis due to increased free radicals. Inhibit calcium ion in-flow, reduce amino acid excitability, and protect nerve cells from damage. Promotes ATP synthesis and reduces the production of inflammatory factors, thereby reducing neuronal effects. The active ingredients flavonoids in Ginkgo biloba extract inhibit the expression of mutated genes after ischaemia and reduce apoptosis.

Antithrombotic

Platelet-activating factor-PAF is the strongest aggregation factor and induces thrombosis. Ginkgolides, an extract of Ginkgo biloba, have been shown to be specific inhibitors of PAF and effective against thrombus formation. Against the phenomena of vasoconstriction and reduced blood flow after ischaemia-reperfusion. Ginkgo biloba leaf extract significantly reduces thrombosis caused by reperfusion and changes the rheology of blood.

Anti-inflammatory

Animal experiments have shown that low, medium, and high doses of Ginkgo biloba leaf extract injection can significantly reduce the concentration of serum ultrasensitive C-reactive protein (hs-CRP) in rats, suggesting that it can exert a certain inflammatory inhibitory effect. In addition, Ginkgo biloba extract injection can inhibit the stimulation of glial cells by lipopolysaccharide to a certain extent, reduce the production of tumour necrosis factor and interleukin-1b, and lower the level of inflammatory factor activity.

Applications:

In Pharmaceutical:

The modern application research and development of Ginkgo biloba began in Germany, the ginkgo biloba preparation "Tibonin" was developed in 1965 by the largest German botanical medicine enterprise, Dr. Weimar Schöppe Pharmaceuticals, and for the first time, a simple extract of Ginkgo biloba was registered, and a patent was filed for EGb761 in 1972, which was used for the treatment and prevention of Alzheimer's disease (dementia), terminal vascular blockage and other diseases. In 2001, the World Health Organisation (WHO) declared EGb761 to be the first choice for the treatment and prevention of cardiovascular and cerebrovascular diseases, making ginkgo biloba extract a globally-recognized killer of cardiovascular and cerebrovascular diseases.

For Health Products:

Ginkgo biloba extract can enhance human immunity, improve sleep quality, relieve fatigue, and so on. In addition, it can prevent and treat Alzheimer's disease, eye diseases, and other diseases. Ginkgo biloba extract powder has been widely used in health supplements, nutritional products, and other products.

For Feed Product:

In the field of veterinary medicine and feed, ginkgo biloba preparation is a kind of all-natural green feed additive, which is also widely used in livestock disease control. Ginkgo biloba extract has an immunomodulatory function, which can improve the anti-oxidative stress ability of livestock, and livestock away from the inhibition of pathogenic microorganisms, prevention of tumors, and no toxic side effects. In addition, Ginkgo biloba extract powder can improve the growth performance of broiler chickens, promote growth, and improve the feed conversion rate.